Bivalirudin utilization in cardiac surgery: Shifting anticoagulation from indirect to direct thrombin inhibition

Canadian Journal of Anesthesia

Volumn 58, Issue 3, 2011, Pages 296-311

  Anand, Sunil X ^a   Viles Gonzalez, Juan F ^b   Mahboobi, Sohail K ^c   Heerdt, Paul M ^d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; THROMBIN;

ACUTE CORONARY SYNDROME; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; CELL PROLIFERATION; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS GRAFT; DIRECT THROMBIN INHIBITION; DOSE RESPONSE; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ELIMINATION; DRUG INDICATION; DRUG MEGADOSE; DRUG MONITORING; DRUG SAFETY; DRUG STRUCTURE; DRUG UTILIZATION; ENZYME INHIBITION; GRAFT PATENCY; HEART SURGERY; HEART TRANSPLANTATION; HEPARIN INDUCED THROMBOCYTOPENIA; HIGH RISK PATIENT; HUMAN; INDIRECT THROMBIN INHIBITION; PRIORITY JOURNAL; SURGICAL MORTALITY; TREATMENT RESPONSE; VASCULAR SMOOTH MUSCLE; VASCULAR SURGERY;

ANTITHROMBINS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; HEPARIN; HIRUDINS; HUMANS; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; THROMBOCYTOPENIA; VASCULAR PATENCY;

EID: 79952281797     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12630-010-9423-0     Document Type: Article

References (108)

1. KW Park 2004 Protamine and protamine reactions Int Anesthesiol Clin 42 135 145 15205644 (Pubitemid 38963099)
2. SE Kimmel M Sekeres JA Berlin N Ellison 2002 Mortality and adverse events after protamine administration in patients undergoing cardiopulmonary bypass Anesth Analg 94 1402 1408 12031996 1:CAS:528:DC%2BD38XkvFSgtLo%3D (Pubitemid 34556613)
3. J Hirsh KA Bauer MB Donati, et al. 2008 Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 141S 159S 18574264 1:CAS:528:DC%2BD1cXptVKiu7w%3D (Pubitemid 351892966)
4. Rosenberg R, Bauer K. The Heparin-Antithrombin System: A Natural Anticoagulant Mechanism. Philadelphia, PA: Lippincott; 1994.
5. U Abildgaard 1993 Heparin/low molecular weight heparin and tissue factor pathway inhibitor Haemostasis 23 Suppl 1 103 106 8388347 1:CAS:528: DyaK3sXktVGnsrs%3D (Pubitemid 23116282)
6. AK Lindahl U Abildgaard R Staalesen 1991 The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitor Thromb Res 64 155 168 1811336 1:CAS:528:DyaK38XltFWksg%3D%3D
7. F Fernandez P N'Guyen J Van Ryn FA Ofosu J Hirsh MR Buchanan 1986 Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect Thromb Res 43 491 495 3764805 1:CAS:528:DyaL28XltVyiu7Y%3D (Pubitemid 16064365)
8. GP Gravlee AT Rogers LM Dudas, et al. 1992 Heparin management protocol for cardiopulmonary bypass influences postoperative heparin rebound but not bleeding Anesthesiology 76 393 401 1539851 1:STN:280:DyaK387ntFantA%3D%3D
9. LC John GM Rees IB Kovacs 1993 Inhibition of platelet function by heparin. An etiologic factor in postbypass hemorrhage J Thorac Cardiovasc Surg 105 816 822 8487561 1:STN:280:DyaK3s3lsVSltA%3D%3D (Pubitemid 23151812)
10. M Sobel PM McNeill PL Carlson, et al. 1991 Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo J Clin Invest 87 1787 1793 2022745 1:CAS:528:DyaK3MXisVSgsbo%3D
11. K Suzuki J Nishioka S Hashimoto 1979 Inhibition of factor VIII-associated platelet aggregation by heparin and dextran sulfate, and its mechanism Biochim Biophys Acta 585 416 426 486540 1:CAS:528:DyaE1MXltVGru74%3D (Pubitemid 9209705)
12. JI Weitz M Hudoba D Massel J Maraganore J Hirsh 1990 Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors J Clin Invest 86 385 391 2384594 1:CAS:528:DyaK3cXlsVCrsbk%3D (Pubitemid 20271869)
13. GJ Despotis JH Joist CW Hogue Jr, et al. 1996 More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT Thromb Haemost 76 902 908 8972009 1:CAS:528:DyaK2sXjvVChsQ%3D%3D (Pubitemid 27013627)
14. GP Gravlee WS Haddon HK Rothberger, et al. 1990 Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation J Thorac Cardiovasc Surg 99 518 527 2308370 1:STN:280:DyaK3c7ntlelsw%3D%3D (Pubitemid 20097779)
15. Okita Y, Takamoto S, Ando M, et al. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization. Circulation 1997; 96 (9 Suppl): II-376-81.
16. GJ Despotis JH Joist CW Hogue Jr, et al. 1995 The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation J Thorac Cardiovasc Surg 110 46 54 7609568 1:STN:280:DyaK2MzjtlyntQ%3D%3D
17. JI Weitz M Crowther 2002 Direct thrombin inhibitors Thromb Res 106 V275 V284 12356489 1:CAS:528:DC%2BD38XnsVWrtLY%3D
18. SX Anand MC Kim M Kamran, et al. 2007 Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin Am J Cardiol 100 417 424 17659921 1:CAS:528:DC%2BD2sXot1ymuro%3D (Pubitemid 47094690)
19. RJ Linhardt NS Gunay 1999 Production and chemical processing of low molecular weight heparins Semin Thromb Hemost 25 Suppl 3 5 16 10549711 1:CAS:528:DyaK1MXntlart74%3D (Pubitemid 29517028)
20. J Hirsh TE Warkentin SG Shaughnessy, et al. 2001 Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety Chest 119 64S 94S 11157643 1:CAS:528: DC%2BD3MXhtlamsrg%3D (Pubitemid 32154195)
21. T Barzu P Molho G Tobelem M Petitou J Caen 1985 Binding and endocytosis of heparin by human endothelial cells in culture Biochim Biophys Acta 845 196 203 3995089 1:CAS:528:DyaL2MXks1Clsbs%3D (Pubitemid 15067878)
22. J Hirsh 1991 Heparin N Engl J Med 324 1565 1574 2027360 1:STN:280:DyaK3M3is1Crtg%3D%3D
23. E Young M Prins MN Levine J Hirsh 1992 Heparin binding to plasma proteins, an important mechanism for heparin resistance Thromb Haemost 67 639 643 1509402 1:STN:280:DyaK38zns1OmsA%3D%3D
24. NJ Mutch LA Robbie NA Booth 2001 Human thrombi contain an abundance of active thrombin Thromb Haemost 86 1028 1034 11686320 1:CAS:528: DC%2BD3MXnvVertLc%3D (Pubitemid 32975829)
25. PJ Hogg CM Jackson 1989 Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy Proc Natl Acad Sci U S A 86 3619 3623 2726739 1:CAS:528:DyaL1MXkt1Wgtr0%3D
26. JI Weitz B Leslie M Hudoba 1998 Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors Circulation 97 544 552 9494024 1:CAS:528:DyaK1cXhsVGrsL0%3D (Pubitemid 28090683)
27. R Bar-Shavit A Eldor I Vlodavsky 1989 Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties J Clin Invest 84 1096 1104 2794047 1:CAS:528:DyaL1MXlvFaitLs%3D (Pubitemid 19247578)
28. JM Teitel RD Rosenberg 1983 Protection of factor Xa from neutralization by the heparin-antithrombin complex J Clin Invest 71 1383 1391 6222069 1:CAS:528:DyaL3sXltlOguro%3D (Pubitemid 13098928)
29. ML Kahn M Nakanishi-Matsui MJ Shapiro H Ishihara SR Coughlin 1999 Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin J Clin Invest 103 879 887 10079109 1:CAS:528:DyaK1MXhvFarsro%3D (Pubitemid 29152634)
30. JG Kelton TE Warkentin 2008 Heparin-induced thrombocytopenia: a historical perspective Blood 112 2607 2616 18809774 1:CAS:528:DC%2BD1cXht1SrtLbE
31. TE Warkentin A Greinacher 2003 Heparin-induced thrombocytopenia and cardiac surgery Ann Thorac Surg 76 638 648 12902132 (Pubitemid 36960635)
32. GM Arepally TL Ortel 2006 Clinical practice. Heparin-induced thrombocytopenia N Engl J Med 355 809 817 16928996 1:CAS:528: DC%2BD28Xos1KmtLo%3D
33. A Greinacher B Farner H Kroll T Kohlmann TE Warkentin P Eichler 2005 Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients Thromb Haemost 94 132 135 16113796 1:CAS:528:DC%2BD2MXms12ks7c%3D (Pubitemid 40974717)
34. A Koster B Spiess M Jurmann CM Dyke NG Smedira S Aronson MA Lincoff 2006 Bivalirudin provides rapid, effective, and reliable anticoagulation during off-pump coronary revascularization: results of the "EVOLUTION OFF" trial Anesth Analg 103 540 544 16931658 1:CAS:528:DC%2BD28Xotlajsb4%3D (Pubitemid 44542900)
35. DE Wallis DL Workman BE Lewis L Steen R Pifarre JF Moran 1999 Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia Am J Med 106 629 635 10378620 1:STN:280:DyaK1MzgsV2ltw%3D%3D (Pubitemid 29279299)
36. TE Warkentin JG Kelton 1996 A 14-year study of heparin-induced thrombocytopenia Am J Med 101 502 507 8948273 1:STN:280:DyaK2s7gsVWjtQ%3D%3D (Pubitemid 126335970)
37. BE Lewis DE Wallis SD Berkowitz, et al. 2001 Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia Circulation 103 1838 1843 11294800 1:CAS:528:DC%2BD3MXjsFGhsLs%3D (Pubitemid 32328395)
38. N Lubenow P Eichler T Lietz 2005 Greinacher A; HIT Investigators Group. Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3 J Thromb Haemost 3 2428 2436 16241940 1:CAS:528:DC%2BD2MXht1KktLzO (Pubitemid 41727158)
39. JT Walls JJ Curtis D Silver TM Boley RA Schmaltz W Nawarawong 1992 Heparin-induced thrombocytopenia in open heart surgical patients: sequelae of late recognition Ann Thorac Surg 53 787 791 1570971 1:STN:280: DyaK383jvVOgtg%3D%3D
40. V Toschi M Lettino R Gallo JJ Badimon JH Chesebro 1996 Biochemistry and biology of hirudin Coron Artery Dis 7 420 428 8889357 1:STN:280: DyaK2s%2FksVartA%3D%3D (Pubitemid 26330645)
41. A Greinacher TE Warkentin 2008 The direct thrombin inhibitor hirudin Thromb Haemost 99 819 829 18449411 1:CAS:528:DC%2BD1cXntFajsrg%3D (Pubitemid 351705298)
42. JM Maraganore P Bourdon J Jablonski KL Ramachandran JW Fenton 2nd 1990 Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin Biochemistry 29 7095 7101 2223763 1:CAS:528: DyaK3cXksFCqsr4%3D (Pubitemid 20241158)
43. JC Vasquez A Vichiendilokkul S Mahmood FA Baciewicz Jr 2002 Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery Ann Thorac Surg 74 2177 2179 12643418 (Pubitemid 35440905)
44. EJ Topol R Bonan D Jewitt, et al. 1993 Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty Circulation 87 1622 1629 8491018 1:STN:280:DyaK3s3lvV2jsg%3D%3D (Pubitemid 23133107)
45. JA Bittl J Strony JA Brinker 1995 et al.Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators N Engl J Med 333 764 769 7643883 1:CAS:528:DyaK2MXoslGqu7c%3D
46. JA Bittl BR Chaitman F Feit W Kimball EJ Topol 2001 Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: final report reanalysis of the Bivalirudin Angioplasty Study Am Heart J 142 952 959 11717596 1:CAS:528:DC%2BD38XisVyquw%3D%3D (Pubitemid 33131801)
47. AM Lincoff JA Bittl NS Kleiman, et al. 2004 Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial) Am J Cardiol 93 1092 1096 15110198 1:CAS:528:DC%2BD2cXjsVelsrY%3D (Pubitemid 38521035)
48. AM Lincoff JA Bittl RA Harrington, et al. 2003 Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial JAMA 289 853 863 12588269 1:CAS:528: DC%2BD3sXht1Ohu7Y%3D (Pubitemid 37430344)
49. SM Bates JI Weitz 1998 Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin Am J Cardiol 82 12P 18P 9809887 1:CAS:528:DyaK1cXnsVyksbs%3D
50. P Eichler N Lubenow U Strobel A Greinacher 2004 Antibodies against lepirudin are polyspecific and recognize epitopes on bivalirudin Blood 103 613 616 14512301 1:CAS:528:DC%2BD2cXmsFChsw%3D%3D (Pubitemid 38140095)
51. I Fox A Dawson P Loynds, et al. 1993 Anticoagulant activity of hirulog, a direct thrombin inhibitor, in humans Thromb Haemost 69 157 163 8456428 1:CAS:528:DyaK3sXitVCqtLs%3D (Pubitemid 23041187)
52. RM Lidon P Theroux M Juneau B Adelman J Maraganore 1993 Initial experience with a direct antithrombin, hirulog, in unstable angina. Anticoagulant, antithrombotic, and clinical effects Circulation 88 1495 1501 8403297 1:STN:280:DyaK2c%2FgslShtQ%3D%3D (Pubitemid 23296896)
53. R Robson H White P Aylward C Frampton 2002 Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender Clin Pharmacol Ther 71 433 439 12087346 1:CAS:528:DC%2BD38XlslCktrc%3D (Pubitemid 34701350)
54. A Koster D Chew M Grundel H Hausmann O Grauhan H Kuppe BD Spiess 2003 An assessment of different filter systems for extracorporeal elimination of bivalirudin: an in vitro study Anesth Analg 96 1316 1319 12707125 1:CAS:528:DC%2BD3sXktVSqt7s%3D (Pubitemid 36512867)
55. C Delhaye G Maluenda K Wakabayashi, et al. 2010 Safety and in-hospital outcomes of bivalirudin use in dialysis patients undergoing percutaneous coronary intervention Am J Cardiol 105 297 301 20102938 1:CAS:528: DC%2BC3cXpslajtg%3D%3D
56. GV Sharma D Lapsley JA Vita, et al. 1993 Usefulness and tolerability of hirulog, a direct thrombin-inhibitor, in unstable angina pectoris Am J Cardiol 72 1357 1360 8256726 1:STN:280:DyaK2c%2FnvV2jsQ%3D%3D (Pubitemid 24005661)
57. V Patella A Ciccarelli B Lamparter-Schummert A de Paulis M Adt G Marone 1997 Heterogeneous effects of protamine on human mast cells and basophils Br J Anaesth 78 724 730 9215027 1:CAS:528:DyaK2sXkslajsL0%3D (Pubitemid 27268086)
58. IJ Welsby MF Newman B Phillips-Bute RH Messier ED Kakkis M Stafford-Smith 2005 Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery Anesthesiology 102 308 314 15681944 1:CAS:528:DC%2BD2MXosVartQ%3D%3D (Pubitemid 40189077)
59. G Stratmann AM de Silva EE Tseng, et al. 2004 Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia Anesth Analg 98 1635 1639 15155316 (Pubitemid 38668904)
60. B Rath DH Bennett 1990 Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty Br Heart J 63 18 21 2178656 1:STN:280:DyaK3c7otFaitA%3D%3D (Pubitemid 20033650)
61. W Dietrich G Dilthey M Spannagl M Jochum SL Braun JA Richter 1995 Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study Anesthesiology 83 679 689 7574046 1:CAS:528:DyaK2MXpsl2jtbs%3D
62. W Dietrich M Jochum 1995 Effect of celite and kaolin on activated clotting time in the presence of aprotinin: activated clotting time is reduced by binding of aprotinin to kaolin J Thorac Cardiovasc Surg 109 177 178 7529346 1:STN:280:DyaK2M7hsFeqsw%3D%3D
63. S de Denus SA Spinler 2002 Clinical monitoring of direct thrombin inhibitors using the ecarin clotting time Pharmacotherapy 22 433 435 11939678 (Pubitemid 34270027)
64. CM Dyke G Aldea A Koster, et al. 2007 Off-pump coronary artery bypass with bivalirudin for patients with heparin-induced thrombocytopenia or antiplatelet factor four/heparin antibodies Ann Thorac Surg 84 836 839 17720385 (Pubitemid 47285016)
65. A Koster D Chew M Grundel M Bauer H Kuppe BD Spiess 2003 Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypass Anesth Analg 96 383 386 12538181 (Pubitemid 36125750)
66. A Koster B Spiess DP Chew, et al. 2004 Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting Am J Cardiol 93 356 359 14759391 1:CAS:528:DC%2BD2cXptFamtw%3D%3D (Pubitemid 38167438)
67. IP Casserly DJ Kereiakes WA Gray, et al. 2004 Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration Thromb Res 113 115 121 15115666 1:CAS:528:DC%2BD2cXjs1eqs7c%3D (Pubitemid 38534488)
68. L Cho K Kottke-Marchant AM Lincoff, et al. 2003 Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations Am J Cardiol 91 1110 1113 12714157 (Pubitemid 36514930)
69. GJ Despotis CW Hogue R Saleem, et al. 2001 The relationship between hirudin and activated clotting time: implications for patients with heparin-induced thrombocytopenia undergoing cardiac surgery Anesth Analg 93 28 32 11429333 1:CAS:528:DC%2BD3MXltl2iurY%3D (Pubitemid 32601147)
70. B Potzsch K Madlener C Seelig CF Riess A Greinacher G Muller-Berghaus 1997 Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass-assessment of the whole blood ecarin clotting time Thromb Haemost 77 920 925 9184403 1:CAS:528:DyaK2sXjsFSrtLs%3D (Pubitemid 27239115)
71. A Koster S Buz T Krabatsch, et al. 2008 Monitoring of bivalirudin anticoagulation during and after cardiopulmonary bypass using an ecarin-activated TEG system J Card Surg 23 321 323 18482390 (Pubitemid 351852565)
72. AM Lincoff NS Kleiman K Kottke-Marchant, et al. 2002 Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET) Am Heart J 143 847 853 12040347 1:CAS:528:DC%2BD38XltFartb4%3D (Pubitemid 34595343)
73. E Cheneau D Canos PK Kuchulakanti, et al. 2004 Value of monitoring activated clotting time when bivalirudin is used as the sole anticoagulation agent for percutaneous coronary intervention Am J Cardiol 94 789 792 15374791 1:CAS:528:DC%2BD2cXnslGgu74%3D (Pubitemid 39221505)
74. ML Zucker A Koster J Prats FM Laduca 2005 Sensitivity of a modified ACT test to levels of bivalirudin used during cardiac surgery J Extra Corpor Technol 37 364 368 16524153 (Pubitemid 351506611)
75. CM Dyke NG Smedira A Koster, et al. 2006 A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study J Thorac Cardiovasc Surg 131 533 539 16515902 1:CAS:528:DC%2BD28XjtleksLg%3D
76. A Koster CM Dyke G Aldea, et al. 2007 Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial Ann Thorac Surg 83 572 577 17257990 (Pubitemid 46156924)
77. AF Merry PJ Raudkivi NG Middleton, et al. 2004 Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery Ann Thorac Surg 77 925 931 14992900 (Pubitemid 38271062)
78. NG Smedira CM Dyke A Koster, et al. 2006 Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study J Thorac Cardiovasc Surg 131 686 692 16515924 1:CAS:528: DC%2BD28Xjtleksb8%3D
79. MJ Mann E Tseng M Ratcliffe, et al. 2005 Use of bivalirudin, a direct thrombin inhibitor, and its reversal with modified ultrafiltration during heart transplantation in a patient with heparin-induced thrombocytopenia J Heart Lung Transplant 24 222 225 15701441 (Pubitemid 40215601)
80. CS Almond J Harrington R Thiagarajan, et al. 2006 Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia J Heart Lung Transplant 25 1376 1379 17097505 (Pubitemid 44692502)
81. O Amir AW Bracey FW Smart RM Delgado 3rd N Shah B Kar 2005 A successful anticoagulation protocol for the first HeartMate II implantation in the United States Tex Heart Inst J 32 399 401 16392229 (Pubitemid 41306805)
82. MA Crouch V Kasirajan W Cahoon GJ Katlaps KJ Gunnerson 2008 Successful use and dosing of bivalirudin after temporary total artificial heart implantation: a case series Pharmacotherapy 28 1413 1420 18957002 1:CAS:528:DC%2BD1cXhsVaqsLfL
83. KB Leissner A Ketchedjian R Crowley R Ortega JF Hesselvik RJ Shemin 2007 Deep hypothermic circulatory arrest and bivalirudin use in a patient with heparin-induced thrombocytopenia and antiphospholipid syndrome J Card Surg 22 78 82 17239224 (Pubitemid 46110430)
84. M Wasowicz A Vegas MA Borger S Harwood 2005 Bivalirudin anticoagulation for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia Can J Anesth 52 1093 1098 16326682 (Pubitemid 43192567)
85. S Stamler BT Katzen AI Tsoukas SZ Baum N Diehm 2009 Clinical experience with the use of bivalirudin in a large population undergoing endovascular abdominal aortic aneurysm repair J Vasc Interv Radiol 20 17 21 19026565
86. SW Finks 2006 Bivalirudin use in carotid endarterectomy in a patient with heparin-induced thrombocytopenia Ann Pharmacother 40 340 343 16449539 (Pubitemid 43269870)
87. EG Avery AD Hilgenberg RP Cambria R Beckerly AM Donnelly M Laposata 2009 Successful use of bivalirudin for combined carotid endarterectomy and coronary revascularization with the use of cardiopulmonary bypass in a patient with an elevated heparin-platelet factor 4 antibody titer Anesth Analg 108 1113 1115 19299772 1:CAS:528:DC%2BD1MXjtlOqsbw%3D
88. VS Kashyap PD Bishop JF Bena K Rosa TP Sarac K Ouriel 2010 A pilot, prospective evaluation of a direct thrombin inhibitor, bivalirudin (Angiomax), in patients undergoing lower extremity bypass J Vasc Surg 52 369 374 20478686
89. BA Anderegg GM Baillie WE Uber, et al. 2008 Use of bivalirudin to prevent thrombosis following orthotopic liver transplantation in a patient with Budd-Chiari syndrome and a history of heparin-induced thrombocytopenia Ann Clin Lab Sci 38 277 282 18715858
90. B Kiaii RS McClure P Stewart, et al. 2008 Simultaneous integrated coronary artery revascularization with long-term angiographic follow-up J Thorac Cardiovasc Surg 136 702 708 18805275
91. CA McNamara IJ Sarembock LW Gimple JW Fenton 2nd SR Coughlin GK Owens 1993 Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor J Clin Invest 91 94 98 8380817 1:CAS:528:DyaK3sXht1aisLY%3D (Pubitemid 23037258)
92. H Noda-Heiny BE Sobel 1995 Vascular smooth muscle cell migration mediated by thrombin and urokinase receptor Am J Physiol 268 C1195 C1201 7762612 1:CAS:528:DyaK2MXlvVajtL0%3D
93. R Kranzhofer SK Clinton K Ishii SR Coughlin JW Fenton 2nd P Libby 1996 Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes Circ Res 79 286 294 8756006 1:STN:280:DyaK28zgsFSnug%3D%3D (Pubitemid 26255881)
94. K Dabbagh GJ Laurent RJ McAnulty RC Chambers 1998 Thrombin stimulates smooth muscle cell procollagen synthesis and mRNA levels via a PAR-1 mediated mechanism Thromb Haemost 79 405 409 9493599 1:CAS:528:DyaK1cXhtVeisLw%3D (Pubitemid 28065893)
95. DR Abendschein D Recchia YY Meng L Oltrona SA Wickline PR Eisenberg 1996 Inhibition of thrombin attenuates stenosis after arterial injury in minipigs J Am Coll Cardiol 28 1849 1855 8962575 1:CAS:528:DyaK2sXks12luw%3D%3D (Pubitemid 26426243)
96. R Gallo A Padurean V Toschi, et al. 1998 Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries Circulation 97 581 588 9494029 1:CAS:528:DyaK1cXhsVGrsLg%3D (Pubitemid 28090688)
97. IJ Sarembock SD Gertz LW Gimple RM Owen ER Powers WC Roberts 1991 Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits Circulation 84 232 243 1829399 1:CAS:528:DyaK3MXlt1Kks7Y%3D
98. E Bretschneider R Kaufmann M Braun G Nowak E Glusa K Schror 2001 Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells Br J Pharmacol 132 1441 1446 11264237 1:CAS:528: DC%2BD3MXivVahs7s%3D (Pubitemid 32281032)
99. A Rothman B Wolner D Button P Taylor 1994 Immediate-early gene expression in response to hypertrophic and proliferative stimuli in pulmonary arterial smooth muscle cells J Biol Chem 269 6399 6404 8119989 1:CAS:528: DyaK2cXitFChsb0%3D (Pubitemid 24191011)
100. J Martinez-Gonzalez M Vinals F Vidal V Llorente-Cortes L Badimon 1997 Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells Atherosclerosis 135 213 223 9430371 1:CAS:528:DyaK2sXntVOisrs%3D (Pubitemid 28015188)
101. Z Liu N Dronadula GN Rao 2004 A novel role for nuclear factor of activated T cells in receptor tyrosine kinase and G protein-coupled receptor agonist-induced vascular smooth muscle cell motility J Biol Chem 279 41218 41226 15272006 1:CAS:528:DC%2BD2cXnslWms7g%3D (Pubitemid 39287724)
102. Z Liu C Zhang N Dronadula Q Li GN Rao 2005 Blockade of nuclear factor of activated T cells activation signaling suppresses balloon injury-induced neointima formation in a rat carotid artery model J Biol Chem 280 14700 14708 15681847 1:CAS:528:DC%2BD2MXjtFSmu78%3D (Pubitemid 40562817)
103. T Tokunou T Ichiki K Takeda Y Funakoshi N Iino A Takeshita 2001 cAMP response element-binding protein mediates thrombin-induced proliferation of vascular smooth muscle cells Arterioscler Thromb Vasc Biol 21 1764 1769 11701463 1:CAS:528:DC%2BD3MXosVKntb4%3D (Pubitemid 34219780)
104. J Martinez-Gonzalez J Rius A Castello C Cases-Langhoff L Badimon 2003 Neuron-derived orphan receptor-1 (NOR-1) modulates vascular smooth muscle cell proliferation Circ Res 92 96 103 12522126 1:CAS:528:DC%2BD3sXntVA%3D (Pubitemid 36105612)
105. H Perlman L Maillard K Krasinski K Walsh 1997 Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury Circulation 95 981 987 9054761 1:STN:280:DyaK2s3gslClug%3D%3D (Pubitemid 27091544)
106. PD Flynn CD Byrne TP Baglin PL Weissberg MR Bennett 1997 Thrombin generation by apoptotic vascular smooth muscle cells Blood 89 4378 4384 9192761 1:CAS:528:DyaK2sXjvFCmu7s%3D (Pubitemid 27260247)
107. TE Warkentin A Greinacher A Koster 2008 Lincoff AM; American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 340S 380S 18574270 1:CAS:528:DC%2BD1cXptVKhsro%3D (Pubitemid 351892970)
108. TE Warkentin A Koster 2005 Bivalirudin: a review Expert Opin Pharmacother 6 1349 1371 16013985 1:CAS:528:DC%2BD2MXmtVert7o%3D